Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
SUCAMPO PHARMACEU-A Add to My Watchlist (NSDQ: SCMP) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Sucampo 3.40 -0.04 (-1.16%) 1,765
4520 East-West Highway
Suite 300
Bethesda, MD 20814 US
(301) 961-3400
(301) 961-3440 fax
www.sucampo.com
CEO Dr. Ryuji Ueno, M.D., Ph.D.
Auditor PricewaterhouseCoopers LLP
Exchange Traded NQ
ISIN Number US8649091068
CIK Number 1365216
NAICS Code 325412
Business Summary
A biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.
Number of Employees 94
Share Fundamentals
Market Cap 53.38M
Shares Outstanding 15.65M
Float 40.33M
Short Interest 288.88K
Financial Strength
Revenue (TTM) $67,424,000
Earnings (TTM) -$5,105,000
Quick Ratio 3.8:1
Current Ratio 3.9:1
Total Debt/Equity 0:1
Profitability
Gross Margin 91.4%
EBITDA Margin -1.1%
Profit Margin -2.1%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs